News

Latest news164

Agilent customer story: Rocío Sampayo, Axent Biosciences

AGILENT - Learn how Axent Biosciences is advancing manufacturing solutions to expand access to cell therapies. Read post

HexemBio looks beyond capital as KIP opens a door to Korea’s biotech network

KOREA TECH DESK – HexemBio, a U.S. preclinical biotech developing therapies designed to rejuvenate aging blood stem cells, announced a USD 10.4 million seed round led by Draper Associates in April 2026. By September, the company said its total funding had reached USD 15.5 million, with Korea Investment Partners investing USD 2 million through the KIPUS Trinitas Fund. Read post
Ali Madani

Profluent and BioMarin Partner to Design Novel Enzyme Therapies Using AI

HLTH – The two companies have entered a collaboration focused on designing and optimizing novel enzyme therapies for BioMarin’s pipeline, combining artificial intelligence-based protein design with the pharmaceutical company’s experience developing enzyme replacement therapies for genetically defined conditions. Read post
Ray Therapeutics logo

Ray Therapeutics Awarded $8 Million CIRM Grant to Advance RTx-021 Gene Therapy for Stargardt Disease

Ray Therapeutics (RayTx), an industry-leading clinical-stage biopharmaceutical company pioneering differentiated vision restoration therapies for those living with severe retinal degenerations, today announced it has been awarded an $8 million grant from the California Institute for Regenerative Medicine (CIRM) to advance RTx-021 for the treatment of Stargardt disease. The funding will support the ongoing Phase 1/2 clinical trial and manufacturing activities to prepare the program for late-stage development. Read post

HexemBio raises $15.5m to rejuvenate aging stem cells

HexemBio recently announced two new therapies under development: an injectable that would deliver results similar to their flagship therapy, without the need to first collect cells from patients, and another therapy aimed at protecting and treating skin. The company, backed by $15.5M in funding, also brought on an additional investor, Happiness Capital. Read post
Root corn spore trapping devices deployed in a corn field

Spraying Fungicide to Protect the Crop in Minnesota

Root Applied Sciences has set up spore capture devices across the southern tier of Minnesota. The company developed its approach while pioneering detection and treatment for diseases that affect grapevines at vineyards. To protect their valuable produce, winemakers were spraying numerous times across a growing season. Root Applied Sciences developed a way of detecting and modeling infection that allowed those growers to cut their application in half. Read post